PRCT PROCEPT BioRobotics Corp

8-K Current Report

Filed: March 6, 2026

Health Care

Surgical & Medical Instruments & Apparatus

PROCEPT BioRobotics Corp (PRCT) 8-K current report filed with SEC EDGAR on March 6, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Board expanded from 8 to 9 members; Daniel Puckett appointed Class III director, term expires at 2027 annual meeting
• Puckett brings strong medtech CFO pedigree — ex-CFO of Shockwave Medical (2016–2024) through its ~$13B J&J acquisition

+2 more insights

Other PROCEPT BioRobotics Corp 8-K Filings

8-K Feb 26, 2026

8-K Feb 25, 2026

Get deeper insights on PROCEPT BioRobotics Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.